key: cord-0009838-fe6la9dj
authors: McKusick, Victor A.
title: The Human Gene Map 15 April 1986: The Morbid Anatomy of the Human Genome
date: 2008-04-23
journal: Clin Genet
DOI: 10.1111/j.1399-0004.1986.tb00562.x
sha: 5cda1e7a918af28b00ad9c92d1d87b4ed7046e96
doc_id: 9838
cord_uid: fe6la9dj

nan

icle Series.

The f i r s t was organized by Dr. Rank Ruddle and held i n New Haven i n June 1973. New Haven (1973) X (3): 1-216, 1974 -13:l-216, 1974 Hcb.I3 Baltimore (1975) XII (7) : 1-452, 1976 -16:l-452, 1976 Edinburgh (1979) xV (11) : 1-236, 1979 -25:2-236, 1979 Los Angeles (1983) XX(2): 1-666, 198/, -37:l-666, 1984 1-666, 198/, -37:l-666, m 8 Helsinki (1985 xXr(4) :1-832, 1985 :1-832, -4O:l-832, 1985 :1-832, Rntterdam (1974 XI (3): 1-310, 1975 -14:162-480, 1975 M4 Wirmipeg (1977) XlV(4) :1-730, 1978 :1-730, -22:l-730, 1978 :1-730, m 6 Oslo (1981 XVIII (2) : 1-343,1982 -323-343, 1982 h v i o u s editions of this mwsletter appeared in Clinical Genetics 22: 359-391, 1982 (Dec.) ; 3 : 89-123, 1984 (-Jan.) .iirl 3: 207-239, 1985 (Feb.) . Fxmples: acid phosphatase-l to glutathione reductase to c h r m s m 8. Imludes CNA dosage, e . g . , fibrinogen loci to 4 2 . 7 , F = linkage s'ady in families; e . g . , linkage of ABO blood group and nail-patella syrdrome. (when a c h r m s a i u l lieteromrphism or r e a r r a n g a n t is one t r a i t , Fc is used; e . g . , Wfy blood g r o p locus on chrmsome 1. when a DNA polymorphism is om t r a i t , Fd may be used; e.g. , Huntington disease on chrmsome 4 . ) It = based on p r e s m d h m l o g y ; e . g . , assignrent of IDHC t o Up.

conservatism of X chromssm in rcmn~ls. HS = W c B & molecular hybridization in solution ('Cot analysis'), e.g., assignrent of Hb beta to chr. 11 in derivative hybrid c e l l s ,

Includes ohno's law of evolutionary 9. 10 . L = lyonization, e . g . , OTC t o X chrcmosm. 11 . LD = linkage disequilibriun, e . g . , beta and delta globin genes (HBB, HBD). 1 2 . M = Microcell mdiated gene transfer (m), e . g . , a collagen gene ( C O W ) to chromssm 17 13. OT = ovarian t e r a t m ( c e n t r a r e mapping), e . g . , pcM3 and c e n t r m r e of chr. 6 16. S = 'segregation' (cosegregation) of cellular traits a d chrmsomes (or s e p n t s of chrmsomes) i n particulilx clones from somatic c e l l hybrids, e . g . , thymidine E w e to chrmsome 17. RFa; w i t h hybridization i n solution, HS.

when w i t h restriction e q m , 17. V = induction of microscopically evident chrmsomal change by ademvirus (probably represents change ccmparabli t o 'puffing' i n insects; accompanied by activation of kinases), e.g., ademvirus 12 changes on chr. 1 and 1 7 .

1 8 X/A = X-autosom translocation i n female with X-linked recessive disorder, e . g . , a s s i p n t of Duchenne msculIu dystrophy to Xp21. 1096 Total (many napped by 2 or more mthods)

The certainty with which a s s i g m n t of loci to c h r m s m s or the linkage between two loci has been established has been graded into the following classes: h m t i o n unhxm, CNA s e p n t s and cell surface antigens, some peptides identified by O'Farrell 2-D electrophoresis and s m antigens identified by rronoclonal antibodies have been mapped. Most of these, w i t h s+ls beginntng ' P ' and 'M' , respectively, have cot been included here except when they have been used for the assigimnt of other loci. Before their distinctxess is established, the initials of the rime of the laboratory are incorporated into the s y i x~l , e.g., MIC7 for seventh Irr@erial h e r mmlonal. liylxidization &r coralitions of low stringercy) also are m t usually l i s t e d here. wed has a 'P' or an 'L' a f t e r the syhol for the regular locus. The location given is often the SRC) (shortest region of overlap) based on a collation of studies of chramsa1l;il recarrar!gent?nts. The statemmt of s e p n t to h i c h the gene is a s s i p d i s inclusive of the band stated second. Vie physical location stated here is often derived fran i n f o m t i o n on linkage t o other loci and on gene order, rather than by direct physical mapping. drf ired earlier.

(1) only capital l e t t e r s , except i n No hyphens, except in KIA (the hyplwi (4) Chrmsorne nuher i n syidMls onlv lhe last m h r refers to the sequence of delineation on a particular ' 2 ' replaces ' S ' i f the CNA f r a p n t contains repetitive sequences. (only a few DNA s e p n t s that h m~ (3) (S-s e p n t ) .

No mre than 4 or 5 l e t t e r s or rum4m-s. 17cen-qter chr.7 chr.16 2q36-q37 REa Beta-glucuronidase (25322) Over 1700 loci are iumm with confideme to exist on a u t o s m s , on the basis minly of characteristic mdeliaii patterns of inheritance of altemtive form of particular traits (see Table IV ). s o m mapping infonmtion is available cotxeminp over 30% of these loci. represent SROs khortest regions of perlap) of various assigmsnts using broken or rearranged chrmsot~~s. S m of the regional assimnts k l u d e infonmtion on gem order to arrive at a shorter region of assignrent, and others represent assignrents mark Mrectly throu& linkage with an 'anchor' locus. In addition to the loci listed here, anonymus DNA sepents, antigens defiEd by mmclonal antibodies, surface antigens, ard fumtion-unlamwn protein spots have been assipd to iniiVidual autosms, as cataloged by HX?, The 5-digit rmher in parentheses after end (certainty o€ assignment);of locus -all capital letters for gene cluster; @EM nmhr); methcd(s) of assipnent; (comnents); ldisorders caused by mtation at that locus --'nondiseases' preceeded by 9~.

As indicated by the following h t ; ?he regiod assipnts on the left A. clrmsomal assimnts (see Fig. 1 ) (10415) (12615) 

A 9C 22 6 

Lh (class I distal to class 11) 6p21.3[HLAA] (C)U-A tissue type (14280) F 6p21.3[HFE] (C)Henrxhranatosis (23520) ID, F (close to U -A ; between HIA-A and HLA-B) IHmhrmtosis [P450C21,CA2H] (C)cangenital adred hyperplasia due to 21-hydroxylase deficiency (20191) F, RE (linked to C2, a, BF; 2 loci, A ind B; only B active) lCongenital adrenal hyperplasia che to 21-hydroxylase deficiewy 6p21.3[C2] (C)Cmplent ccqcmnt-2 (21700) F, ID, RE (m crossover with BF; 2% recd. with HLA-B)IC2 deficiercy 6p21,3[ckS,ckA] (C)Cciq&mnt ccxprent-4S, or ckA (12081) F, H, RE, Fd (on HLA-B side of CAB)

C)HLA-cR tissue type (14286) F, RE (1 alpha, 3 beta chains)

Ex alpha, 1 Ex beta; 1 IX alpha, 1 Ix: beta chains) 6p21.3[HIADP] (C)HIA-DP tissue type (14288) F, RE (3 alpha, 3 beta chains) 6p21.3[MG,ITG] (P)Blastogenic r e w e to synthetic plypeptides (14695, 14696) F (in A/B sepnt) 6p21.3[IPHEG,IW] (P)Blastogenic response to synthetic polypeptides (14681, 14682) F (in B/D sepnt) 6p21,3[IGLPl] (C)Inmw response to synthetic polypeptides (14708) F 6p21

25655) H, F (?linked to HLA; see chr. 10) ISialidosis 6p21.3-p21.2[GLOl] (C)Glyoxalase I (13875) F, S (ca. 3cM proximal to HIA) 6p21.2-q12[SW] (C)Spinocerebellar ataxia-1 (16440) F (?between GLOl and FOB

C)onCogene, Kirsten rat s a r m virus-1 (19011) REa, A (pseudogene) 6p[CSCI] (L)Corticosterone side-chain ismerase (12255) H (?linked to MHC) 6q12[MEl] (C)Malic enzyme, soluble (1yt25) S 6q12[pcED] (C)Pnosphoglucamtase-3 (17210) S, F, OT 6q12-q21[cGA] (P)Chorionic gonadotropin, alpha chain (11885) REa (shared with LH, FSH, TSH) 6q16-q22[MCF3] (P)onCogew MCF3 (16493) A 6q21[EUW] (P)=d hait mimr satellite CNA-1, related to heterogzwtic sex (10978) A 6q21[SOD2] (C)Superoxide disrutase-2, mitochotdrial (14746) S 6q22-q24[!4YB] (C)onCogene, avian nyeloblastosis virus (18999) S, A 6q25-qter[FUW] (C)Alpha-L-fucosidase-2 (13682) F (linked to PIG

C)Baboon M7 virus replication (10918) S Cnr.6[ARGl] (P)Argimse, liver (20780) REalArgininema

Temperature sensitivity ccmplmntation, cell cycle specific, ts546 cell line (18733) S Chr.6

Primed lymphocyte test-1 (17668) F (M HL4-D) including X and perbps Y)

P)T-cTlex ~OCUS Tcp-1 (18698) REa, H In addition: 11 protein spot, 4 pseudogenes, 1 'like' gene ard 5 fragile sites (W)

PL-obable order

Order i n region of class I genes

tUADP (fomrly called HIA-SB, for 'secardary B-cell response') s h relatively high recdination with CQ but the physical distame by mlecular studies is about saw as CQ-to-DR. Recdinational hotspots probably exist within the CQ subregion and between HLA-A and HLA-C (which ndecular data suggest are as close as B and C)

JX4 sepnts, 1 antigen defined by a mmclonal, 1 surface antigen (18551), a d 1 0' Fan-el

20 pseudogenes also) 7pter-q22[NFf] (P)Neuropeptide Y (16264) REa 7pter-q22[FSP] (C)Fhosphoserice phosphatase (17248) S 7p21.3-p21.2[CSO] (L)Craniosynostosis (12310) ChlCraniosynostosis 7p21-q22[ASL] (P)ArgininOsuccinate lyase (20790) S IArginimsuccinicacidria 7p15[TCX] (C)T-cell antigen receptor, gamna subunit (18697) REa 7p14-p12[ERBB] (C)onCogene E?BB (19014) REa (?sam as m; similar sequences) 7pl&cen[BLVR] (C)Biliverdin rehtase (10975) S 7pl3JGCPSl (L)Greig craniopolysyxlacqly syrdrm (17570) Ch (see 3~21.1; balanced translocation) IGreig 7p13-pll

20 in all: 1 on X chr. ; 7q22-qter[CPA] (P)Carboxypeptidase A (11485) REa (both CPA ard ?RyL = serine proteases) 7q22-qter[GP130,NM] (C)Neutrophil migration; g r d o c y t e glycoprotein (16282) D (fomrly neu&ophil chmtactic response, NCR) 7q22-qter[TRYl] (P)nyPsin-l (27600) REAl'hypsinogen deficieccy 7q22-qter[BCP,CBT] (P)Blue c m pigment (19090) REalTritan colorblbxkess 7q35[TCRB] (C)T-cell antigen receptor, beta submit (18693) RFa, A (7q32 by A; cluster of V, D, J , and C pews) 7q35-q36[BND3] (P)J%cd 3 of red cell d r a m (10927) REa, A, F 7q36[M] (P)P-glycoprotein-1 (17105) REa, A Chr

C)Follicle stirmlating h o r n , beta polypeptide (13653) D, REa llp13 [WAGR] (C)Wilms tmor/aniridia/gonadoblastorra/retardation complex (19407) Ch IWAGR complex Ilpl3[cAT] (C)Catalase (11550) S , D (KX8 suggested order: cen-CAT-WT-AN-pter) 1Acatalasemia llp13-q22[GST3] (C)Glutathiow S-transferase-3 (13837) S (fomrly called GST1) llp12.08-p12.03[LMIA] (C)Iactate dehydrogewe A (15000) S, D, REb, CIEkertid nyoglobiwia c h~ to deficiency llpll.2-pll[cpSC] (C)(WHEPSIN GENE CILJSTE' R (11681, 11684) S llpll.2-pll[CPSD] (P)Cathepsin D (11684) S llpll.2-pll[CPSB] (P)Cathepsins B, H, L (11681) S (llp13-pll) llpll-q12[ACP2] (C)Acid phosphatase-2 (17165) S lLysosd acid phosphatase deficierlcy llp[INLu] (P)Lutheran inhibitor, domimint; n m o c l o~l antibody A3D8 (11115) S llp[RRM1] (P)Ribomcleotide redxtase, K l subunit (18041) S llq12.1-q13.5[FNI2] (L)Fihi-o=ctin (13561) S , A (by A: llq12.1-q13.5 in germ line cells only) llq13[AHILPl] (C)AFOLIHIpRDTEIN CWSTE' R I (10768, 10772, 10769) RE llq13[AFWL] (C)Aplipoprotein A-I (10768) REa, RE (?llq23-qter) ICmbined @-I and @-I11

Mw1 (15807) S Chr.ll[BVlX] ( P ) W virus induction, xemtropic (11399) S

P)Collagenase; recessive epidemlysis bullosa dystrophica (22660) SIEpidPnmlysis lx111os~1

P)Ferritin, heavy chain (13477) REa, A Chr.ll[HVlS] (P)Herpes vim sensitivity (14245) S (see chr. 3)

Chr.ll[LEzn] (P)Leu-7 antigen of natural killer lyqhocytes

29 antigens, ix)t necessarily all separate and different, defined by nnxclordl antibodies ( e . g . , 14304, 15806, 15807), and 1 O'Fa1~i.11 protein spot (HcM8)

Gemtic rrap (M) : Cen-CAT-18% -cALc1-8%-pIH-12$-HBBc-10%-INS-30%-HRASl-pter . Map of apolipaprotein cluster I : ?&en or llqter---5' -AFWL-3

C)von Willebrd factor (19340) A, REalvon Willebrd disease 12pter-q12[BC711] (C)Brded chain a n r h acid minotransferase-l(ll352) S lHyperleucirn?mia-isoleucim?rnia or hypervaliwnia 12pter-q14[INIl] (P)Oxogene INll, mine nmnnwy m e r virus (16482) REa 12p13[TPI1] (C)Triosephosphate ismrase (19045) S, D, R, REalHerralytic anemia due to triosephosphate ismrase 12p13.31-p13.1[GApD] (C)Glyceraldehyde-3-phosphate dehydrogemse (13840)

protein (16872) F (P; a d PIF closer to G1 and DB than FR or P11) 12p13.2[R.I] (C)Parotid middle b a d protein (16878) F (linked to

C)Parotid prolire-rich protein Pc (16871) F (linked to PS) 12p12.2-p12,1[IB!B] (C)Iactate dehydrogenase B (15010) S , D 12p12.2-p12,1[LCHC] (L)Iactate dehydrogenase C (15015) H (closely linked to LIXIB in other species) 12p12.1[RASKZ,KRILS2] (C)onCogene Kras-2, Kirsten rat sarccm vim (19007) S , F 12pll-qter

C)Elastase-1 (13012) REh (on proximal 12p

(12014) REa, A 12q21[PEPB] (C)Peptidase B (16990) S 12q22-q24.1[IGFl] (C)Insulin-like grmth factor I, or somatomedin C (14744) REh, A 12q24.1[IFI,IFG,IFNG] (C)Interferon, g m m or i m n m type (14757) S, A (3 introns; IFF, IFL mm) 12q24.1[A(U,PAH] (C)pherrylal& hydroxylase (26160) RFa, AIPnenylketormia Chr.l2[A2M] (C)Alpha-2-mroglobulMcroglobulin (10395) REa Chr

18556), 3 O'Farrell protein spots (ME)

Inmmoglobulin E level (14705) F (very close to ED) 13q14[WD,wTJD] (C)Wilson disease (27790) F (vs. E D , muc. lcd = 5.49, theta = 0.03) IWilson disease 13q14[XFS] (L)X-ray sewitivity

Osteosarm (25950) C k (probably s a m locus as retitmblastorra) /Osteosarcm 13q14.1-q14.3[ICPl] (P)Lymphocyte cytosolic protein-1 (15343) F, D 13q34[cBTL] (L)Carotid body m r -1 (16800) F (?linked to factors VII and X) ]Carotid body tumr 13q34[F7] (C)Clotting factor VII (22750) DlFactor VII deficiency 13q34[FlO] (C)Clotting factor X (22760) D, A, &[Factor X deficiersy 13q34[cOLkA2] (P)Collagen IV alpha-2 chain (12009) RFa, A Chr.l3[KLA] (P)Propionyl COA carboxylase, alpha. subunit (23200) REalPropionicacidemia, type I or pccA type Chr

18045) A lhqll.2[KXA] (C)T-cell antigen receptor, alpha subunit (18688) H, REa, A (cen

innurde ficiency che t o 14q21-q31[Fos] (P)onCogene FDS, F W mire osteosarcm virus (16481) REa, A 14q21-qter[W] (C)TLyptophanyl-tRNA spthetase (19105) S 14q22-qter[PFGS] (P)€hosphorfbosyl fomylglycinmidiw synthetase (10258) S (?EFT, PFGS = 1 m l t i k t i o i w l e w w ) 14q22-qter

Fc (see 2p25) I Cataract, anterior polar 14q31-qter[M~] (P)Alpha-l-anti&ynntrypsin (10728) REa, A 14q32[(xBB] (C)Creatine kinase, brain type (12328) S 14q32[CKBE] (P)Creatke b e , brain type, ectopic expression of (12327) F (linked t o IGN, PI; ?sam locus a s (233) I W r e a t k kinase, brain type

AlUl (16473) REa, A (prox. t o IB1; ?identical to m, 18696) 14q32.33[1W] (C)Variable region genes (14707) REa, RE, A (a. 250 genes

D = diversity) 14q32.33[IGKJ] (C)J region genes (14701) RE, REa, A (more than 4 genes

33[IGW2] (C)Constant region of heavy chain of I @ (14703) RE, REa, A 14q32.33[IBID] (C)Constant region of heccJy chain of IgD (14717) RE, REa, A 14q32,33[IGEG2] (C)Cmstant region of heavy chain of IgG2 (14711) RE, REa, A (5'-G2-1%-&-3'; closeness of 14q32.33[IGX4] (C)Constant region of heavy chain of I@ (14713) RE, REa, A 14q32.33[IW3] (C)Constant region of heavy chain of IgG3 (14712) RE, REa, AAS (close linkage with G1 indicated 14q32.33[IWl] (G)Constant region of heavy chain of IgGl (14710) RE, REa, A, AAS 14q32.33[IBIE] (C)Constant region of heavy chain of I@ (14718) RE, REa, A 14q32.33[IQEP1] (C)Constant region of heavy chain of IgEX' l (14716) RE, REa, A (IGEP2 on chr. 9; 14721) 14q32.33[IQ1A1] (C)Cmstant region of heavy chain of I & (14690) RE, REa, A 14q32.33[IBIA2] (C)Constant region of heavy chain of I & ! (14700)

&lHolt-Oram syndrcrre 14q32.33[IM] (C)IM%NXXORJLIN HEAVY C " CZNE CWSTER (14690-14718) REa, A 3' c e n t r m r i c , 5' telmric

IGG3 a d 1021 lumm from Lepore-like myeloma protein) by Lepore-like q e l m protein

Congenital cataract (11670) F (?linked to HP)ICmgenital cataract 16q22.1[HP] (C)Haptoglobin (14010) Fc, A (just distal to fral6q22.1) 16q22.1[HR] (C)Haptoglobin-related locus

ecithin-cholestrol acyltransferase (24590) F, ID, A (very close to HP)lNolum disease Chr.l6[cLRB] (P)&,mtrypsirOgen B (11889) REa (19% AA h c m l o~ to HP)

Cystathionase (21950) SJKCystathi-ia Chr.l6[ESB3] (P)F.sterase-B3 (13329) S Chr.lb[HM3f (P)Glyoxalase 11

16 [DIPI ,VDI] (P)Vesicular stcmatitis virus defective interfering particle repressor (12526) S

A (10385) REa (others mapped to chr. 22) In addition: Order: Chr.l6[CRW] (L)CryStallin, alpha-B (12359) REa 2 amqmous DNA sepnts

C)Myosin, cardiac heavy chain, alpha -adult (16071) A 17pter-pll[MYHCB] (C)Myosin heavy chain, beta -fetal (16076) A (5' to M C 4 ) 17pter-pll[MYHSA1] (C)Myosin heavy chain, adult-1 (16073) REa 17pter-pll[WH%?] (C)Myosin heavy chain, adult-2 (16074) REa 17pter-pll[bRHSEl] (C)Myosin heavy chain, dryonic-1 (16072) REa 17p13.3JMDIS1 (P)Miller-Dieker lissemephaly qdrm (24720) &lMiller-Dieker lissencephaly syndr-17p13

avian erythroblastic leukemia virus (19012) REa 17q21[ERBB2] (P)hogene m -B 2 (19015) E & , A 17q21-q22[NGL] (P)hogene NGL; orxogene IEU, muro-or glioblastma derived (16487) REa, A 17q21-q22

A (at 5' end) ]Isolated g o d homne deficiency, 17q21.0-q22.0[~] (C)Growth h o r n , variant (13925) S, REa, A 17q21.0-q22,O[CSL] (C)(horionic sara!anmIDtropin-like (see 15020) S, REa, A 17q21.0-q22.0[PL,csH1,CSA] (C)Chorianic samatmanrmtrapin A (15020) S , REa, AI*Placental lactogen deficiency 17q21.0-q22,O[CSB] (C)Chorionic sara!anmIDtropin B (see 15020) S, REa, A

C)U2 SnRNA GENE CWSTER (18069) REa, A deficiency by A; spanning ca. 45kb)

Chr.l7[AzMI3] (P)Aldehyde dehydrogenase-3 (10066) S Chr.l7[AIccc] (P)Aldolase C (10387) REb

Placental alkalim phosphatase-like genes (see 17180) RFa Chr.l7[ca<BB2] (L)Creatine b e , brain type, second locus (see 12328) S In addition: 3 amnymus DNA sepnt, 2 antigens defined by a mmlonal antibody

Multiple hereditary cutaneous leiomyomta (15080) &[Multiple hereditary cutaneous l e i q m t a 18q21,3[BCI2] (C)oI-sogene B-cell le&mia/lyniphm-2 (15143) Ch, REIB-cell leukemia/lyqhm; follicular lynphoina 18q21.3[YESl] (C)Cmogem YES-1 (16488) RFa 18q21.31-qter[TS] (C)%pidylate synthase (18835) S 18q22-qter[MBP] (P)Myelin basic protein (15943) REa

P)Dihydrofolate reductase pseudogem-1 (see 12606) REa (shows +/-polymrphism)

IFNGZz] (I)Interferon, gmm, receptor for (10747) S (see 6q for altemative assipnt)

C)Insulin receptor (14767) REa, A (1 gem for alpha a d beta subunits) I?leprecha&sm

7cM i n ndes vs. C3 RFLP)IC3 deficiency 19p13.2-p13.1[LDIR,FHC] (C)Familial hypercholesterolemia; IDL receptor (14389) F, REa (ca. 2OcM fran 19p13.2-cen[M1] (C)Myotonic dystrophy (16090) F (ca. 5cM from PEE)) IHyotonic dystrophy 19p13.2-q13.2 [MANB] (C)Lysosml alpha-D-mmmsidase-B (24850)

C)Peptidase D; prolidase (17010) S, F, H (closely linked to Apoc2) IProlidase 'deficiency 19p13-q13[SE] (C)Secretor (18210) F (H, SE = alpha-L-fucosyltransferases; from ccrmyxl amestral genes) 19p13-q13[W] (C)Lutheran blood group (11120) F (linked to SE)

C-I (10771) RFa, RE (secand APOCl gene on 19) 19cen-ql3 .2[GPI] (C)Glwosephosphate ismrase (17240) S , DlHemolytic amnia due to glucosephosphate ismrase deficiency 19q13

Wl = earlii 19q13.1-q13.3[n;l.B] (P)Transforming growth factor, beta type (19018) REa, A ?

I Familial hypercholesterolemia -1 )

C)Cmplemntation of QK1 DNA-repair defect W20 (12638) SI?fonn of xerodem pigmentosun, 27870 19q13.3-q13.4[Fn] (C)Ferritin, light chain (13479) S, A, REa

)Baboon M7 virus receptor (10919) S (?scum as virus FD114 receptor) Chr.l9[GUSM] (P)kta-gl-onic!ase, muse, modifier of (23161) S k

P)Cmp1arentation of QD DNA-repair defect EN9 (12634) SI?Blocm syxirm

Coxsackie B3 virus susceptibility (12005) S Chr.l9[EF2] (P)Elongation factor-2 (13061) S In addition: 9 armynws DNA sepnts and 3 cell surface antigens defined by monoclonals (HX8)

FHC-C3-ApoE/AKX2. AKX1 6kb 3' to AHIE. respectively) /?Male pseuQhermaphroditism due to defective H hyperleucinemia-isoleucinemia IDIR

C)Protcmcogene SRC, Rats sarcm (19009) RFa, A 2@13.2-qter[AM] (C)Ademsine deamimse (10270) S, D, REalSevere cdined innmode ficiemy che to ADA deficiency Chr.2O[BIRF] (C)Growth h o r n releasing factor; smtmrinin (13919) RFa, REbI?Isolated growth homne Chr.2O[W,ARVP] (P)Argk vasopressin (19234) RFal?Diabetes insipib, 1 form Chr

P)Neuraninidase/beta-galactosidase expression; galactosialidosis (25654) S lGalactosialidosis In addition: deficiercy c b to defect in Q%?I 6 mnym3us DNA sepnts ani 1 '

A (21q22) IHwnocystimia 2lq21-qter[IFNAR] (C)Antiviral protein; alpha-interferon receptor (10745) S, D 2lq21-qter[IFNER] (C)AntiViral protein; beta-interferon receptor (10746) S, D 21q22[PFKL] (C)Fhosphofructokinase, liver type (17186) S, DlHmlytic anemia due to phosphofmtokinase deficiency 21q22.lfPAISI (P)Pnosphoribsylamimminoimidazole synthetase (17244) S (this a d PRGS

C)Breast cancer estrogen-itducible sequerce (11371) RFa, A Chr.21[LGWB,MFl7] (P)Cell adhesion molecule, leukoojte, beta subunit (11692) S Chr.21[CF%N] (PfCrystallFn, alpha A (12358) REa (alpha B on another chr

L) 5 -hydroxyOyptamim oxygenase regulator (14346) D In addition: over 30 anxlyrmus DNA sepnts, 1 surface antigen (18559) and 3 antigens defined by mmlonals (HCW3)

RNA (18045) A 22p12-qll[CES] (C)Cat eye sydrcm (11547) Ch, A, D (partid tetrasay of 22pter-q11)IG.t eye sydrm 22pl2-qll

C)DiGeorge syralrcrne (18840) ChIDiGeorge sydrm

C)Variable region of lankla light chains (14724) REa, A (mny genes) 22q11.12[IGU] (C)J region of lakda. light chains (14723) REa, A (several genes) 22q11,12[IGIC] (C)Cbn.stant region of l d d a light chains (14722) RFa, A (several gems) 22q11.2-q13[MB] (C)Nyoglobin (16003) RFa, Fd 22q11.2-q13.31[AcO2] (C)Aconitase, mitochordrial (10385) S 22q11.2-qter[Pl] (P)Pl blood group (11141) F, Fd (?linked to DIAl and SIS) 22q11.2-qter[TC2] (P)Transcobalamin I1 (27535) F (linked to P1) ITranscobalamin I1 deficiency 22q11.3[CML,BcR1] (C)Chronic nyeloid leukemia

IEWing sarcoma 22q12.3-q13.1[SIS,PF] (C)Cmogem SIS; platelet derived growth factor, B chain (19004) RFa, Fd 22q13[NAGA] (C)N-acetyl-alpha-D-galactosaminidase; alpha-galactosidase B (10417) S 22q13-qter[GLE52] (C)Beta-galactosidase-2; GIB protective protein (10968) S 22q13

16 by s m workers)I?Aldolase A deficiency In addition: kiurler-Scheie s y d r c r~ to 3

a m r y~~u s CNA segwnts and 1 surface antigen (18558) (HcM8)

Linked autosd loci for which assimnt to a specific c h r m s m has rmt yet been achieved (Wassigned Linkage Groups

All published data: lod = 8.94 at theta 0.14, but evidence of heterogeneity.) C6 and C7 linked in dog

Two C7 loci 2. in dog. In man, C6 and C7 genes physically close by CNA studies (RE), Linkage supported by observation of cdixed deficiersy (Lachm

Ii blood group (11080) Congenital cataract (21250) (?c, F) Epidenrolysis bullosa progressiva , EBR3 (22650) Hypoacusis (KAC; a recessive partial deafness) (22070) (?c, F) ?

From hamlogy to tyrosine-wgative albinism i n the muse, which is linked to the beta-globin cluster (8cM apart) and to d i c enzyme, mitochondria1 (M apart), on muse chromosm 7

Hy-prgonadotropic hypgonadim (23832) (m, F)

16, but also very weakly for chrmscme 13 ( M ) . linkage group is as follows: Glutamate pyrwate t r a m b e

VMDl (15384) -Epidemlysis bullosa, O w type, E X 1 (13195) -closely linked to GETl (Linkage of breast cancer

Coqlemnt ccnpnent-4 b i d i n g protein

Chplemnt component C3b, receptor for; C3BR (12062) Coqlerrent component C3d, receptor f o r ; C3cR (12065) C c q l m n t factor H

A Source Book for

.) s , a factor (or factors) which detemims the differenti.ation of the (See Davis

Xp as the cause of XX d e s was suggested by Ferguson-Smith (1966) and found confirmation in severdl observations

Serological cross reactivity between H-Y (mle) antigens of muse and m n . -PNllS 71.: The strong likelihood that the locus that detennines heterogametic sex detennimtion and that for the

See also Wachtel ?t a l . , New %. J . E d . 295: 750, 1976. H-Y and 'IIIF may be otx and the same

Work by ohno using recomhitmlt CNA probes for H-Y suggests that the Y -l i n k e d locus is regulatory, m t structural, and that the structural IOCLL., an amient hmlogue, is on Xp

Ran the s t d y of XX d e s , it can be coxluded that the H-Y determinant on the Y (whatever its nature) and TDF are separate entities a d m t closely situated (Simpson, E.: 'Ihe H-Y antigen a d sex reversal

Tne existerne of factors controllbg spemtogenesis on the ronfluorescent part of the long arm of Y (distal part of Yqll) w a s suggested by study of 6 men w i t h deletion of this s e p n t and azoospennia

XY md XYY gemtypes; that the effect of the Y chrmsm on stature is mdiated throu& a iia3chuUstn other than axfrogen is suggested by the tall stature of persons w i t h XY gonadal dysgenesis (30610)

Genes on the Y chrcxmsm~ influeXing r a t e of maturation in m. Lamet 11: 141.144, ?he postulated locus is s y h l i z e d STA (for 'stature'). Yamada e t al. @&I . -t

1979) suggested, on the basi! of tooth size i n i d e s of various Y c h r a m s m constitutions, that a Y-chrmsomal gene controlling tooth size i: ira;lependent of the testis-determining gem ard is carried by Yqll ( s y h l i z e d TS for 'tooth size, ' o r , more recently i n M 8 , Alvesalo and de l a Cnapelle

regions of the Y chrmso1113, as w e l l as at least 23 DNA s e p n t s that imp t o lmth tlie Y a d the X, so1113 that map to both to the Y and an a u t o s m , and s m repetitive DNA

1979) map to the heterochrctMtic portion of Yq and are pre.cxm&ly genetically inert because persons lackmg these

identified on the Y chrmso1113 is tl-tat hmlogous t o the X -1 i i -h gem for surface antigen MIC2

See Fig. 1 of Polani, b. mt. 60: 207, 1982, and of See MIM 31U7

the Y chromosm kzs been thought to have several subregions: (1) an X-Y homologous meiotic pairing region occupying mst of Yp and perhaps irrluding a pseudoautosanal region of X-Y exchange; (2) a pericentric region containing the sex detennining gene(s); and (3) a long ann heterochrmtic genetically inert region. As mted abwe, s o 1 1 1 3 recent findings support the classical model, hereas others refute it. sequences m t hmlogous to Xp but with hamlogy to Yq, Xq, or an a u t o s m . s i p d to the X c h r c m s m by the s m methods used i n autosanal mapping: interspecies sornatic c e l l hybridization

Chm's law of the evolutionary conservatimi of the X c h r m s a

X-autosane translocations in females affected by X-linked recessive disorders (X/A)

Inmost instances, the 'confidence of assipxmt' s y h l s (C, P, L) qply to the regional localization

X-linked; placental steroid sulfatase Xpter-p22.32[XG] (C)Xg blood group (31470) F, D Xpter-p22.32[CPX,CDPX] (P)Chorrk~splasia pumtata, X-linked (30295) X/AIChondroctysplasia punctata, X-linked Xp22[AIC] (P)Aicardi symlraw (3W5) X/AIAicardi syndra Xp22

Forsius-Eriksson type (30060) F (?linked to XG) [ocular albinism, Forsius-Eriksson type Xp22[W] (C)&ular albinism, Nettleship-Falls type (30050) F, Fd (linked to XG) /ocular albinism

or repressor (30697) Ch (?structural HY locus on X)

Xp21.3-p21.2[Q(] (C)Glycerol W e deficieccy (30703) D, Fd (?GK and AHX = 1 locus) IGlycerol Erase deficiency .Xq21.3-p21.22[AHX,AHC] (C)F'rinmy adred hypplasia (30020) D, Fd ( ? s m locus as GK-deficiency) IPrimary adrenal hypoplasia Xp21.2[MDD,DMD] (C)hrhenne rmscular $ystrophy (31020) X/A, Fd, DILhcheme mu;cular $ystrophy Xp21.2[BMD] (C)Becker mcular dystrophy (31010) Fd, ?X/A (probably allelic to DMD) IBecker mscular dystrophy Xp21

C)Ghronic grdomatous disease (30640) F, D (also Rp a d El4E with deletion

proximal to El4E)IOmithke transcartmylase deficiemy Xp21-pll[G4PDPl] (C)Glyceraldehyde-3-phosphate dehydrogewe pseudogene-1 (30598) REa, A Xpll

C)Retinitis pipntosa, X-linked (31260) Fd (3cM prox. to E 7 ; seemingly inconsistent with Xp21

Xpll, 2-cen[ASLHN] (P)Alport-syndra-like hereditary mphritis (30105) Fdl Alprt-syndrm-like hereditary

C)Incontimntia pipnti (30830) X/A (Xq21 = conflicting localization) I Incontinentia pigmnti Xpll[W] (P)Wiskott-Aldrich syndrane (30100) FdlWiskott-Aldrich @ a

C)Testicdar feminization; androgen receptor (31370) S (B. Migeon thinks proximal Xq) ITesticdrir faninization Xqll-q13[FGKLPl] (C)Fhosphoglycerate kiwe-pseudogem-1 (31181) REa, A Xqll.2-q21,1[XCE] (P)X chrmsane controlling elmnt; X-inactivation center (31467) Ch (Xq13) Xq12[iCA] (C)Anhidrotic ectodemd dysplasia (30510) X/A, HlAnhidrotic ectodennd dysplasia Xq13[A4S ,my] (P)kskog-Scott syxlrm

P)i%noamk oxidase A (30985) S (mar pQ

C)Phosphoglycerate b e -1 (31180) S, R

P)Sideroblastic anemia (30130) C h (somatic cell chranosa rearrangement) ISideroblastic anemia Xql3-q21[cMM,W] (P)&armt-Marie-Tooth disease, X-linked (30280) Fd (linked to DXYS1) ICharcot-Marie-Tooth Xq13-q21[TCD] (C)Choroideremia (30310) Fd (0.0 recdination w i t h DXYS1)ILhoroideremia XqU-q22

)X-linked agamraglobulhmia (30030) H, FdlX-linked agamaglobuli-a Xq22[GIA] (C)Alpha-galactosidase A (30150) S, R Xq22-q26 [ PRPS] (C)hsphorihsylpyrophosphate synthetase (31185) S , RI Pnosphoribosylpyrophosphate def iciency Nettleship-Falls type deletion firdings; ?2 fonns of RP on Xp

C)knke~ syndra (30940) Fclknkes syndrome faciogenital dysplasia disease, X-linked synthetase-related gout

C)Glutamate ddydrogenase pseudogere-1 (30591) REa, A Xq25[LccR] (P)M oculocerelmrd syndrarr? (309CY.I) X/A

FdlIesch-Nyhan Xq26-q27.2[=] (P)Tenprabxe sensitivity

MPter splranz; sulfoi&rmate sulfatase deficiency (30990) X/A, Fd, F (?linked to Xq27.1-q27.2[HEMB,F9] (C)H8nophilia B; factor M (30690) REa, A, Fd, D (distal to HRT; prox. paa of Xq27.3[FRpxA] (C)Fragile site Xq27.3; Martin-Bell syrdram? (30955) Ch, F, FdlMartin-Bell symlram?

C)Protan colorblFt.rfness; red cone p i p n t (30390) F (linked to G6pD) IProtan colorblindness Xq28[EMD,SFS] (P)&ery-Dreifuss rmscular dystrqhy; scaplloperoneal sydrm, 31285 (31030) F, Fd (linked to Xq28[G6pD] (C)Gl~r,ose-6-phoqhate ddrydrogenase (30590) F, SIG6pD deficiency Xq28[?KcR] (P)Gognirne ?xcx syndrane (31430) X/A (distal to G6pD)IGognirne ?KcR sp3xn-e Xq28[HEM4,F8C] (C)Herophilia A; factor VIII (30670) F, Fd, REa (linked to G6pD, CB) IHamphilia A Xq28[XN] ( P ) h (31490) F (linked to E B , ECB) In addition: a t least 181 amqnms DNA segpmts, m a y with Iaum RFIPs, 4 o r~